z-logo
open-access-imgOpen Access
Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance
Author(s) -
Tetsuhiro Okada,
Yusuke Mizukami,
Yusuke Ono,
Hiroki Sato,
Akihiro Hayashi,
Hidemasa Kawabata,
Kazuya Koizumi,
Sakue Masuda,
Shinichi Teshima,
Kuniyuki Takahashi,
Akio Katanuma,
Yuko Omori,
Hirotoshi Iwano,
Masataka Yamada,
Tomoki Yokochi,
Shingo Asahara,
Kazumichi Kawakubo,
Masaki Kuwatani,
Naoya Sakamoto,
Katsuro Enomoto,
Takuma Goto,
Junpei Sasajima,
Mikihiro Fujiya,
Jun Ueda,
Seiji Matsumoto,
Kenzui Taniue,
Ayumu Sugitani,
Hidenori Karasaki,
Toshikatsu Okumura
Publication year - 2020
Publication title -
journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.33
H-Index - 114
eISSN - 1435-5922
pISSN - 0944-1174
DOI - 10.1007/s00535-020-01724-5
Subject(s) - surgical oncology , digital polymerase chain reaction , hepatology , abdominal surgery , stage (stratigraphy) , colorectal surgery , medicine , mutation , pancreatic cancer , polymerase chain reaction , dna , cancer research , oncology , gene , biology , genetics , cancer , paleontology
Cell-free DNA (cfDNA) shed from tumors into the circulation offers a tool for cancer detection. Here, we evaluated the feasibility of cfDNA measurement and utility of digital PCR (dPCR)-based assays, which reduce subsampling error, for diagnosing pancreatic ductal adenocarcinoma (PDA) and surveillance of intraductal papillary mucinous neoplasm (IPMN).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom